Cancer BiologybioRxivPreprint
Preclinical Results: Canine Phase I Safety Study of CM-101, a Tumor Capillary Specific Streptococcal Polysaccharide Toxin, for application in Spontaneous Canine Cancer
Rhett W. Stout, Bonnie B. Boudreaux, I Horia Inegulescu, Roger A. Laine
This study evaluates the safety of CM-101, a tumor-targeting toxin, in healthy dogs, finding no adverse effects at a 10x human dose.
1 citation